|
|
||||||||
Department of Radiology, Toyama Medical and Pharmaceutical University, Toyama City, Toyama, Japan
Correspondence: For correspondence or reprints contact: Hikaru Seto, MD, Department of Radiology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama City, Toyama, 930-01, Japan.
ABSTRACT
We present a case of 201Tl accumulating thymic carcinoma, in which sequential CT scans demonstrated a steady decrease in tumor volume. The presence of a residual mass on CT scans after the completion of therapy presented the clinical dilemma of whether or not a viable tumor remained. Sequential 201Tl SPECT images demonstrated a marked decrease in tumor uptake. At 2 wk after therapy, no significant accumulation of 201Tl in the region of the residual mass was observed, indicating a lack of viable tumor. A biopsy specimen revealed no tumor cells. Sequential histopathologic findings were correlated well with the findings of 201Tl SPECT rather than those of CT. Thallium-201 SPECT is of great clinical value in assessing tumor viability in the course of therapy.
Key Words: thallium-201 SPECT viability thymic carcinoma computed tomography
This article has been cited by other articles:
![]() |
T. Iwata, K. Inoue, S. Mizuguchi, R. Morita, T. Tsukioka, and S. Suehiro Thymic Small Cell Carcinoma Associated With Pulmonary Squamous Cell Carcinoma Ann. Thorac. Surg., December 1, 2006; 82(6): 2266 - 2268. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |